CHNA
Loncar China BioPharma ETF
CHNA
13,53
0,00 Bil. AUM
0,8% Expense Ratio
9,77 NAV
Loncar China BioPharma ETF Profile
About Loncar China BioPharma ETF
The Advisor attempts to invest all, or substantially all, of its assets in the component securities and depositary receipts that make up the index. The index seeks to track the performance of a modified equal-weighted portfolio of companies directly involved in the growth of China's pharmaceutical and biotech related industries.
- Company
- Holdings
- 57
- CUSIP
Loncar China BioPharma ETF Sectors
| Industry | Percentage |
|---|---|
| Other | 87,50% |
| Healthcare | 12,50% |